From 1 October 2024, invasive group A streptococcal infection (iGAS) has been added to Aotearoa New Zealand’s schedule of notifiable diseases.
This places new legal requirements on health practitioners and laboratories for the management and reporting of both suspected and confirmed iGAS cases.
While it is anticipated that the role for those working in primary care and community healthcare services for iGAS notifications will be limited, the following guidance provides further information for your awareness.
Skin prick testing is a specialised test to detect specific IgE antibodies to a range of allergens. Due to the very low volume of skin prick tests processed at Pathlab Taupō, and in commitment to service quality, Pathlab has discontinued skin prick testing at this site. Patients will instead be booked for the same testing at a different site, the closest being Rotorua – OPD Department – Rotorua Hospital.
Read moreAntibiotic treatment for patients aged 15 years and older with moderate cellulitis funded by ACC. Oral antibiotic therapy is the preferred option.
View detailsThis BPAC resource assists to predict risk of serious illness in children with fever